Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

To join this study, people must be between 18 and 80 years old. They must have had an ischemic stroke (a stroke caused by a blood clot) that is confirmed by a brain scan like a CT or MRI. The stroke symptoms must have started less than 24 hours before they get the first dose of the study drug.

There are also some criteria about how severe the stroke is, as measured by a specific scale used by doctors (NIHSS score between 8 and less than 20). Patients who are in a coma or have a very severe reduction in consciousness are not suitable for this study. People who have had a previous stroke and fully recovered before this new ischemic stroke might be eligible.

People cannot join if they are having certain other treatments for their stroke, such as surgery or special procedures that go inside blood vessels. Also, if a scan shows any bleeding in the brain (which is a different type of stroke), they cannot take part. The study team will review all medical information to see if someone is a good fit.

If you join this study, you would receive either the study drug, sovateltide, or a placebo (a dummy treatment, like normal saline, which looks the same but has no active drug). You will also receive the standard medical care for your stroke. The study team will give you specific appointments for the medication and follow-up care.

During your participation, doctors and nurses will closely monitor your health and recovery. This will likely involve regular medical examinations, brain scans, and assessments to measure your stroke recovery and how well you are doing. You would need to be available for these visits and follow-up checks for a set period to allow researchers to gather all the necessary information.